324 related articles for article (PubMed ID: 12187959)
61. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
[TBL] [Abstract][Full Text] [Related]
62. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
63. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
64. Prognosis by tumor location in adults with spinal ependymomas.
Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
[TBL] [Abstract][Full Text] [Related]
65. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
66. Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.
Yi W; Haapasalo H; Holmlund C; Järvelä S; Raheem O; Bergenheim AT; Hedman H; Henriksson R
Clin Neuropathol; 2009; 28(1):21-7. PubMed ID: 19216216
[TBL] [Abstract][Full Text] [Related]
67. Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis.
Modena P; Buttarelli FR; Miceli R; Piccinin E; Baldi C; Antonelli M; Morra I; Lauriola L; Di Rocco C; Garrè ML; Sardi I; Genitori L; Maestro R; Gandola L; Facchinetti F; Collini P; Sozzi G; Giangaspero F; Massimino M
Neuro Oncol; 2012 Nov; 14(11):1346-56. PubMed ID: 23076205
[TBL] [Abstract][Full Text] [Related]
68. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma.
Yang P; Hirose T; Hasegawa T; Seki K; Sano T; Hizawa K
Cancer; 1995 Aug; 76(4):618-25. PubMed ID: 8625155
[TBL] [Abstract][Full Text] [Related]
69. Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas.
Gupta RK; Sharma MC; Suri V; Kakkar A; Singh M; Sarkar C
J Neurooncol; 2014 Jan; 116(2):267-74. PubMed ID: 24178439
[TBL] [Abstract][Full Text] [Related]
70. Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas.
Bennetto L; Foreman N; Harding B; Hayward R; Ironside J; Love S; Ellison D
Neuropathol Appl Neurobiol; 1998 Dec; 24(6):434-40. PubMed ID: 9888153
[TBL] [Abstract][Full Text] [Related]
71. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
Preusser M; Wolfsberger S; Czech T; Slavc I; Budka H; Hainfellner JA
Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
[TBL] [Abstract][Full Text] [Related]
72. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
[TBL] [Abstract][Full Text] [Related]
73. Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
Tzaridis T; Milde T; Pajtler KW; Bender S; Jones DT; Müller S; Wittmann A; Schlotter M; Kulozik AE; Lichter P; Peter Collins V; Witt O; Kool M; Korshunov A; Pfister SM; Witt H
Oncotarget; 2016 Sep; 7(38):61860-61873. PubMed ID: 27556362
[TBL] [Abstract][Full Text] [Related]
74. Immunohistochemical analysis of p18INK4C and p14ARF protein expression in 117 oligodendrogliomas: correlation with tumor grade and clinical outcome.
Korshunov A; Golanov A
Arch Pathol Lab Med; 2002 Jan; 126(1):42-8. PubMed ID: 11800646
[TBL] [Abstract][Full Text] [Related]
75. The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.
Schröder R; Ploner C; Ernestus RI
Neurosurg Rev; 1993; 16(2):145-50. PubMed ID: 8345908
[TBL] [Abstract][Full Text] [Related]
76. Prognostic relevance of global histone 3 lysine 9 acetylation in ependymal tumors.
Ebrahimi A; Schittenhelm J; Honegger J; Schluesener H
J Neurosurg; 2013 Dec; 119(6):1424-31. PubMed ID: 24116725
[TBL] [Abstract][Full Text] [Related]
77. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
78. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
79. A case of cervicomedullary junction tanycytic ependymoma associated with marked cyst formation.
Ito T; Ozaki Y; Nakagawara J; Nakamura H; Tanaka S; Nagashima K
Brain Tumor Pathol; 2005; 22(1):29-33. PubMed ID: 18095101
[TBL] [Abstract][Full Text] [Related]
80. Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.
Hagel C; Treszl A; Fehlert J; Harder J; von Haxthausen F; Kern M; von Bueren AO; Kordes U
J Neurooncol; 2013 Apr; 112(2):191-7. PubMed ID: 23371454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
